INTERNATIONAL PATENT: OPTIPHARM CO., LTD., 주식회사 옵티팜 FILES APPLICATION FOR "TRANSGENIC CLONED PIG FOR XENOTRANSFUSION AND XENOTRANSPLANTATION WITH PORCINE GGTA1, CMAH, IGB3S AND Β4GALNT2 GENES DELETED AND HUMAN CD59 GENE KNOCKED-IN AND METHOD FOR PRODUCING SAME"

GENEVA, June 24 -- OPTIPHARM CO., LTD. (63, Osongsaengmyeong 6-ro, Osong-eup, Heungdeok-gu,Cheongju-SiChungcheongbuk-do 28158), 주식회사 옵티팜 (충청북도청주시흥덕구 오송읍 오송생명6로 63) filed a patent application (PCT/KR2023/020782) for "TRANSGENIC CLONED PIG FOR XENOTRANSFUSION AND XENOTRANSPLANTATION WITH PORCINE GGTA1, CMAH, IGB3S, AND Β4GALNT2 GENES DELETED AND HUMAN CD59 GENE KNOCKED-IN, AND METHOD FOR PRODUCING SAME" on Dec 15, 2023. With publication no. WO/2025/127214, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application w...